Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditis

Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditis

Show other versions (2)

This study aimed to investigate the serum levels of the cytokine TNF-α and its soluble receptors (sTNFR1 and sTNFR2) in patients with toxoplasmosis retinochoroidits (TR) and controls. 37 patients with TR and 30 subjects with positive serology for toxoplasmosis but without history and signs...

Full description

Bibliographic Details
Main Authors:	Thais Fontes Bessa, Cynthia Azeredo Cordeiro, Roberto Martins Gonçalves, Lucy H. Young, Wesley R. Campos, Fernando Oréfice, Antônio L. Teixeira
Format:	Article
Language:	English
Published:	Elsevier 2012-12-01
Series:	Brazilian Journal of Infectious Diseases
Subjects:	Toxoplasmosis Uveitis TNF-alpha Soluble TNF receptors
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702012000600007

Similar Items

Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditis
by: Thais Fontes Bessa, et al.

Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditis
by: Thais Fontes Bessa, et al.
Published: (2012-11-01)

Vision-Related Quality Of Life And Depression In Brazilian Patients With Toxoplasmic Retinochoroiditis
by: Jacqueline Souza Dutra Arruda, et al.
Published: (2021-11-01)

Intravitreal Clindamycin as First-Line Therapy for Toxoplasmic Retinochoroiditis: A Case Series
by: Verma L, et al.
Published: (2020-12-01)

Serum Soluble Tumor Necrosis Factor Receptors 1 and 2 Are Early Prognosis Markers After ST-Segment Elevation Myocardial Infarction
by: Alexandre Paccalet, et al.
Published: (2021-09-01)

Occurrence of anterior uveitis in patients with spondyloarthritis treated with tumor necrosis factor inhibitors: comparing the soluble receptor to monoclonal antibodies in a large observational cohort
by: Gisèle Khoury, et al.
Published: (2020-04-01)

The effect of capsaicin on circulating biomarkers, soluble tumor necrosis factor and soluble tumor necrosis factor-receptor-1 and -2 levels in vivo using lipopolysaccharide-treated mice
by: Yoshio Ijiri, et al.
Published: (2014-01-01)

Transmembrane TNF and Partially TNFR1 Regulate TNFR2 Expression and Control Inflammation in Mycobacterial-Induced Pleurisy
by: Husnu Uysal, et al.
Published: (2018-07-01)

Susceptibility to pulmonary tuberculosis: host genetic deficiency in tumor necrosis factor alpha (TNF-α) gene and tumor necrosis factor receptor 2 (TNFR2)
by: Ehsan Ghamari, et al.
Published: (2016-01-01)

Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis
by: Lei Bao, et al.
Published: (2003-02-01)

<title language="por">Características clínicas de 64 indivíduos portadores de uveítis posterior activa presumiblemente toxoplásmica en Pernambuco Clinical characteristics of 64 individuals carrying active posterior presumptively toxoplasmic uveitis, in Pernambuco
by: Maria Isabel Lynch, et al.
Published: (2008-02-01)

Serial measurement of the circulating levels of tumour necrosis factor and its soluble receptors 1 and 2 for monitoring leprosy patients during multidrug treatment
by: Rosane Dias Costa, et al.
Published: (2013-12-01)

Entwicklung und Charakterisierung von TNFR2-spezifischen Agonisten
by: Klein [geb. Geiger], Christina
Published: (2017)

Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients
by: Esmaeil Mortaz, et al.
Published: (2021-04-01)

Roturas retinianas em retinocoroidite por toxoplasmose: série de casos Retinal tears in toxoplasmic retinochoroiditis: case series
by: Daniel da Rocha Lucena, et al.
Published: (2009-12-01)

Targeting sTNF/TNFR1 Signaling as a New Therapeutic Strategy
by: Roman Fischer, et al.
Published: (2015-03-01)

Glucocorticoids Regulate the Vascular Remodeling of Aortic Dissection Via the p38 MAPK-HSP27 Pathway Mediated by Soluble TNF-RII
by: Lei Zhang, et al.
Published: (2018-01-01)

TNFR1 and TNFR2 in the Control of the Life and Death Balance of Macrophages
by: Harald Wajant, et al.
Published: (2019-05-01)

Inhibitors of tumor necrosis factor-a and mechanisms of their action
by: Bufan Biljana, et al.
Published: (2020-01-01)

TUMOR NECROSIS FACTOR-α MEMBRANE-BOUND AND SOLUBLE RECEPTORS IN NORM AND IN RHEUMATOID ARTHRITIS
by: A. A. Alshevskaya, et al.
Published: (2012-05-01)

Serum levels of neurotrophic factors in active toxoplasmic retinochoroiditis
by: Cynthia Azeredo Cordeiro, et al.
Published: (2017-03-01)

Preclinical and clinical aspects of TNF-α and its receptors TNFR1 and TNFR2 in breast cancer
by: Isela Martínez-Reza, et al.
Published: (2017-12-01)

Development of neoplasms in pediatric patients with rheumatic disease exposed to anti-tumor necrosis factor therapies: a single Centre retrospective study
by: Alexandra Okihiro, et al.
Published: (2018-03-01)

Temporal Ordering of Inflammatory Analytes sTNFR2 and sTREM2 in Relation to Alzheimer's Disease Biomarkers and Clinical Outcomes
by: Jagan A. Pillai, et al.
Published: (2021-06-01)

The Role of TNFR2 and DR3 in the In Vivo Expansion of Tregs in T Cell Depleting Transplantation Regimens
by: Jose-Ignacio Rodriguez-Barbosa, et al.
Published: (2020-05-01)

Current standardized therapeutic approach for uveitis in Japan
by: Kazuichi Maruyama
Published: (2019-07-01)

Profile of adalimumab and its potential in the treatment of uveitis
by: Balevic SJ, et al.
Published: (2016-09-01)

The effectiveness of adalimumab treatment for non-infectious uveitis
by: Eiichi Hasegawa, et al.
Published: (2019-04-01)

The Efficacy and Safety of Infliximab in Refractory Noninfectious Uveitis: A Meta-Analysis of Observational Studies
by: Anji Xiong, et al.
Published: (2021-09-01)

TNFR2 Signaling Regulates the Immunomodulatory Function of Oligodendrocyte Precursor Cells
by: Haritha L. Desu, et al.
Published: (2021-07-01)

Toxoplasmic retinochoroiditis and hydrocephalus
by: Rekhi Gulbir, et al.
Published: (1991-01-01)

Characteristics and management of ocular sarcoidosis
by: Hiroshi Takase
Published: (2021-06-01)

Efficacy and safety of adalimumab in the treatment of non-infectious uveitis: a meta-analysis and systematic review
by: Ming S, et al.
Published: (2018-07-01)

Comportamiento de la toxoplasmosis ocular activa en el Instituto Cubano de Oftalmología "Ramón Pando Ferrer" Behavior of the active ocular toxoplasmosis in patients of the "Ramón Pando Ferrer" Cuban Institute of Ophthalmology
by: Eddy Mesa Hernández, et al.
Published: (2011-06-01)

Retinocoroidite toxoplásmica em pacientes com AIDS e neurotoxoplasmose Toxoplasmic retinochoroiditis in patients with AIDS and neurotoxoplasmosis
by: Jane Mary Alves, et al.
Published: (2010-04-01)

Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes
by: Richard J MacIsaac, et al.
Published: (2019-11-01)

Biological therapy in refractory cases of uveitis and scleritis: An analysis of 18 cases from a tertiary eye care center from South India
by: Soumen Sadhu, et al.
Published: (2020-01-01)

Conventional immunosuppressive therapy in severe Behcet’s Uveitis: the switch rate to the biological agents
by: Hande Celiker, et al.
Published: (2018-10-01)

Transmembrane TNF and Its Receptors TNFR1 and TNFR2 in Mycobacterial Infections
by: Andy Ruiz, et al.
Published: (2021-05-01)

Patterns of uveitis in children presenting at a tertiary eye care centre in south India
by: Narayana Kannan, et al.
Published: (2003-01-01)